COLB vs GSK · P/E 12, rev $1.63B vs P/E 13, $103.31B cap
Columbia Banking System Inc (COLB) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Columbia Banking System Inc (COLB) is a banks - regional company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported COLB revenue for 2026-06-30 was $1.63B. Net income was $400.0M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. COLB currently screens at market cap $8.58B and trailing P/E 11.6.
GSK does not have a complete income-statement cache yet.
COLB currently screens at market cap $8.58B and trailing P/E 11.6. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the COLB and GSK stock pages for the full models.
Not investment advice.